EMD-51635

Single-particle
5.06 Å
EMD-51635 Deposition: 24/09/2024
Map released: 24/12/2025
Last modified: 24/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-51635

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9gvg summary report (pdf.gz) Map-9gvg FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

P116 from Mycoplasma pneumoniae in complex with mild growth suppressor monoclonal antibody

EMD-51635

Single-particle
5.06 Å
EMD-51635 Deposition: 24/09/2024
Map released: 24/12/2025
Last modified: 24/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mycoplasmoides pneumoniae M129, Mus musculus
Sample: Binary complex of mild growth suppressor monoclonal antibody with P116 protein from Mycoplasma pneumoniae.
Fitted models: 9gvg

Deposition Authors: Vizarraga D , Marcos Silva M, Martin Romero J, Guerra P , Fita I , Pinyol J
Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions.
PUBMED: 41402265
DOI: doi:10.1038/s41467-025-66129-5
ISSN: 2041-1723